The reduced recovery time and minimized risk factors have made it a preferred choice in cases of severe aortic stenosis.

BACKGROUND: Many studies have explored whether individual plasma protein biomarkers improve cardiovascular disease risk prediction. We sought to investigate the use of a plasma proteomics-based ...

Sg2, a Vizient company, has published a white paper on the effects of the rapid increase in cardiovascular disease and related challenge of timely patient access to lifesaving interventions such as ...

In this retrospective cohort of patients with atrial fibrillation (AF) who underwent transcatheter aortic valve replacement ...

While statins can reduce LDL levels and ASCVD events, high Lp(a) poses an independent risk that will need attention, too.

UK King’s Daughters is pleased to welcome structural heart specialist Ravi Gurujal, M.D., to King’s Daughters Medical ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, showcased 2-year follow up data from the ALIGN-AR Trial at TCT 2024. Concurrently, the ...

enrolled patients with aortic stenosis and a scheduled TAVR procedure. Most centers offering TAVR in the United Kingdom. participated. The primary endpoint was stroke within 72 hours of the TAVR ...

Along with age and location, your dog’s breed can significantly impact your pet insurance costs. Certain breeds are more ...

In a trial that many are calling landmark, transcatheter aortic valve replacement had better outcomes than surveillance for ...

The RHEIA trial studied women with severe aortic stenosis and found that participants preferred transcatheter aortic valve replacement over surgical valve replacement.

The NOTION-3 study investigated if routine revascularization with PCI and transcatheter aortic valve replacement improves ...